GL1X · GenesisL1 explorer

Research workbench

Bovine PKA C-alpha in complex with 3-pyridylmethyl-5-methyl-1H- pyrazole-3-carboxylate

Analyse Bovine PKA C-alpha in complex with 3-pyridylmethyl-5-methyl-1H… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4IE9
Type
protein
Length
357 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp-dependent protein kinase catalytic subunit alpha; Camp-dependent protein kinase…
EC
2.7.11.11
UniProt
P00517, P61925
Ligands
PZX
Pockets
6 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 36% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACamp-dependent protein kinase catalytic subunit alpha (EC 2.7.11.11)protein33736% helix, 17% strandP00517
ICamp-dependent protein kinase inhibitor alphaprotein2030% helix, 10% strandP61925

Ligands and binding sites

  • PZX · pyridin-3-ylmethyl 5-methyl-1H-pyrazole-3-carboxylate · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14110.810.8944PZX, GOL
21120.430.7819empty
3770.430.7913empty
41010.360.7414empty
5580.300.7521empty

Interfaces

1 interface between chains.

  • A–I · 1031 Ų buried · 24 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 4IE9 · Bovine PKA C-alpha in complex with 3-pyridylmethyl-5-methyl-1H-pyrazole-3-carboxylate · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.